Does OLMESARTAN Cause Therapeutic product effect incomplete? 49 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 49 reports of Therapeutic product effect incomplete have been filed in association with OLMESARTAN. This represents 2.2% of all adverse event reports for OLMESARTAN.
49
Reports of Therapeutic product effect incomplete with OLMESARTAN
2.2%
of all OLMESARTAN reports
0
Deaths
47
Hospitalizations
How Dangerous Is Therapeutic product effect incomplete From OLMESARTAN?
Of the 49 reports, 47 (95.9%) required hospitalization, and 32 (65.3%) were considered life-threatening.
Is Therapeutic product effect incomplete Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for OLMESARTAN. However, 49 reports have been filed with the FAERS database.
What Other Side Effects Does OLMESARTAN Cause?
Sprue-like enteropathy (391)
Diarrhoea (313)
Gastrointestinal disorder (276)
Acute kidney injury (209)
Weight decreased (197)
Hypotension (176)
Drug ineffective (131)
Dizziness (115)
Hypokalaemia (110)
Dyspnoea (106)
What Other Drugs Cause Therapeutic product effect incomplete?
ALBUTEROL (8,496)
ADALIMUMAB (6,986)
PREDNISONE (6,709)
METHOTREXATE (6,037)
TOFACITINIB (4,914)
SECUKINUMAB (4,661)
BUDESONIDE\FORMOTEROL (4,392)
TIOTROPIUM (4,327)
MEPOLIZUMAB (4,106)
ETANERCEPT (3,961)
Which OLMESARTAN Alternatives Have Lower Therapeutic product effect incomplete Risk?
OLMESARTAN vs OLMESARTAN MEDOXOMIL
OLMESARTAN vs OLMETEC
OLMESARTAN vs OLODATEROL
OLMESARTAN vs OLODATEROL\TIOTROPIUM
OLMESARTAN vs OLOPATADINE